1117465

Regeneron Pharmaceuticals Inc — FEI 1000521995

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tarrytown, NY (United States)

Additional Details

Bioanalytical BA/BE